129 related articles for article (PubMed ID: 38854669)
1. Determining diagnostic delays in Romanian multiple myeloma patients using the Aarhus statement.
Irimia R; Badelita S; Barbu S; Cirlan IL; Zidaru L; Coriu D
Front Med (Lausanne); 2024; 11():1372907. PubMed ID: 38854669
[TBL] [Abstract][Full Text] [Related]
2. Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.
Koshiaris C; Oke J; Abel L; Nicholson BD; Ramasamy K; Van den Bruel A
BMJ Open; 2018 Jun; 8(6):e019758. PubMed ID: 29934381
[TBL] [Abstract][Full Text] [Related]
3. The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.
Petrova D; Špacírová Z; Fernández-Martínez NF; Ching-López A; Garrido D; Rodríguez-Barranco M; Pollán M; Redondo-Sánchez D; Espina C; Higueras-Callejón C; Sánchez MJ
PLoS Med; 2022 Oct; 19(10):e1004110. PubMed ID: 36264841
[TBL] [Abstract][Full Text] [Related]
4. Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes.
Dapkevičiūtė A; Šapoka V; Martynova E; Pečeliūnas V
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31163661
[No Abstract] [Full Text] [Related]
5. Factors influencing patient and health care delays in Oropharyngeal Cancer.
Nieminen M; Atula T; Bäck L; Mäkitie A; Jouhi L; Aro K
J Otolaryngol Head Neck Surg; 2020 Apr; 49(1):22. PubMed ID: 32326977
[TBL] [Abstract][Full Text] [Related]
6. Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.
Howell DA; Smith AG; Jack A; Patmore R; Macleod U; Mironska E; Roman E
BMC Hematol; 2013 Oct; 13(1):9. PubMed ID: 24238148
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Estimates of delays in diagnosis of cervical cancer in Nepal.
Gyenwali D; Khanal G; Paudel R; Amatya A; Pariyar J; Onta SR
BMC Womens Health; 2014 Feb; 14(1):29. PubMed ID: 24533670
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study.
Hansen RP; Olesen F; Sørensen HT; Sokolowski I; Søndergaard J
BMC Health Serv Res; 2008 Feb; 8():49. PubMed ID: 18307790
[TBL] [Abstract][Full Text] [Related]
10. Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records.
Shephard EA; Neal RD; Rose P; Walter FM; Litt EJ; Hamilton WT
Br J Gen Pract; 2015 Feb; 65(631):e106-13. PubMed ID: 25624306
[TBL] [Abstract][Full Text] [Related]
11. Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs.
Surrey E; Soliman AM; Trenz H; Blauer-Peterson C; Sluis A
Adv Ther; 2020 Mar; 37(3):1087-1099. PubMed ID: 31960340
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic delay and complications for older adults with multiple myeloma.
Friese CR; Abel GA; Magazu LS; Neville BA; Richardson LC; Earle CC
Leuk Lymphoma; 2009 Mar; 50(3):392-400. PubMed ID: 19294556
[TBL] [Abstract][Full Text] [Related]
13. Extent and Predictors of Delays in Diagnosis of Cervical Cancer in Addis Ababa, Ethiopia: A Population-Based Prospective Study.
Dereje N; Addissie A; Worku A; Assefa M; Abraha A; Tigeneh W; Kantelhardt EJ; Jemal A
JCO Glob Oncol; 2020 Feb; 6():277-284. PubMed ID: 32109158
[TBL] [Abstract][Full Text] [Related]
14. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients.
Hansen RP; Vedsted P; Sokolowski I; Søndergaard J; Olesen F
BMC Health Serv Res; 2011 Oct; 11():284. PubMed ID: 22027084
[TBL] [Abstract][Full Text] [Related]
15. Delays in the diagnosis and treatment of lung cancer.
Salomaa ER; Sällinen S; Hiekkanen H; Liippo K
Chest; 2005 Oct; 128(4):2282-8. PubMed ID: 16236885
[TBL] [Abstract][Full Text] [Related]
16. [How long does a myeloma patient currently wait for the diagnosis in Hungary?].
Varga G; Mikala G; Andrikovics H; Masszi T
Orv Hetil; 2014 Sep; 155(39):1538-43. PubMed ID: 25240875
[TBL] [Abstract][Full Text] [Related]
17. When months matter; modelling the impact of the COVID-19 pandemic on the diagnostic pathway of Motor Neurone Disease (MND).
Burchill E; Rawji V; Styles K; Rooney S; Stone P; Astin R; Sharma N
PLoS One; 2023; 18(1):e0259487. PubMed ID: 36706102
[TBL] [Abstract][Full Text] [Related]
18. Barriers and Explanatory Mechanisms of Delays in the Patient and Diagnosis Intervals of Care for Breast Cancer in Mexico.
Unger-Saldaña K; Ventosa-Santaulària D; Miranda A; Verduzco-Bustos G
Oncologist; 2018 Apr; 23(4):440-453. PubMed ID: 29284758
[TBL] [Abstract][Full Text] [Related]
19. Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.
Bowcock S; Atkin C; Iqbal G; Pratt G; Yong K; Neal RD; Planche T; Karunanithi K; Jenkins S; Stern S; Arnott S; Toth P; Wandroo F; Dunn J; Drayson MT;
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444449
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
Atkin C; Iqbal G; Planche T; Pratt G; Yong K; Wood J; Raynes K; Low E; Higgins H; Neal RD; Dunn J; Drayson MT; Bowcock S; ;
Br J Haematol; 2021 Mar; 192(6):997-1005. PubMed ID: 32798327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
